Multicenter Study
Pre-operative bevacizumab, capecitabine, oxaliplatin and radiation among patients with locally advanced or low rectal cancer: a phase II trial.
Eur. J. Cancer. 2012 Jan 1; 48 (1): 37-45.
Clinical Trial
Neoadjuvant capecitabine and oxaliplatin followed by synchronous chemoradiation and total mesorectal excision in magnetic resonance imaging-defined poor-risk rectal cancer.
J. Clin. Oncol. 2006 Feb 1; 24 (4): 668-74.
Article
A phase II trial of neoadjuvant IMRT-based chemoradiotherapy followed by one cycle of capecitabine for stage II/III rectal adenocarcinoma.
Radiat Oncol. 2013 Jan 1;8:130.